Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
ChemMedChem ; 19(10): e202300473, 2024 May 17.
Article in English | MEDLINE | ID: mdl-38230842

ABSTRACT

The synthesis and pharmacological activity of a new series of dual ligands combining activities towards the α2δ-1 subunit of voltage-gated calcium channels (Cavα2δ-1) and the µ-opioid receptor (MOR) as novel pain therapeutics are reported. A careful exploration of the pharmacophores related to both targets, which in principle had few common characteristics, led to the design of novel compounds exhibiting both activities. The construction of the dual ligands started from published Cavα2δ-1 ligands, onto which MOR ligand pharmacophoric elements were added. This exercise led to new amino-acidic substances with good affinities on both targets as well as good metabolic and physicochemical profiles and low potential for drug-drug interactions. A representative compound, (2S,4S)-4-(4-chloro-3-(((cis)-4-(dimethylamino)-4-phenylcyclohexyl)methyl)-5-fluorophenoxy)pyrrolidine-2-carboxylic acid, displayed promising analgesic activities in several in vivo pain models as well as a reduced side-effect profile in relation to morphine.


Subject(s)
Analgesics , Calcium Channels , Pain , Receptors, Opioid, mu , Animals , Humans , Male , Rats , Analgesics/pharmacology , Analgesics/chemistry , Analgesics/chemical synthesis , Calcium Channels/metabolism , Calcium Channels/chemistry , Dose-Response Relationship, Drug , Ligands , Molecular Structure , Pain/drug therapy , Receptors, Opioid, mu/metabolism , Receptors, Opioid, mu/antagonists & inhibitors , Structure-Activity Relationship
2.
Histopathology ; 66(2): 270-82, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25307864

ABSTRACT

AIMS: Epigenetic changes are of crucial importance in cancer development and are potentially reversible; they are therefore targets of interest for anti-cancer therapy. The aim of this study was to investigate the clinical prognostic value of the histone deacetylases SIRT1, HDAC1 and HDAC2 and the histone modifications H4K16Ac and H3K56Ac in colorectal cancer. METHODS AND RESULTS: The epigenetic markers were immunohistochemically stained on tissue microarrays containing colorectal tumours (n = 254) and normal colorectal tissues (n = 50). Nuclear expression was assessed on the semi-automated Ariol system. Multivariate trend survival analyses of the combined markers showed better patient survival and less tumour recurrence when more markers showed high nuclear expression. For the combination of the histone deacetylases and H3K56Ac, the hazard ratio (HR) for overall survival (OS) was 0.82 [95% confidence interval (CI) 0.72-0.94; P = 0.005] and the HR for distant recurrence-free survival (DRFS) was 0.77 (95% CI 0.64-0.92; P = 0.003) per additional marker showing high expression. Similarly, for the combination of histone deactylases and H4K16Ac, HRs of 0.86 (95% CI 0.76-0.97; P = 0.01) for OS and 0.79 (95% CI 0.68-0.93; P = 0.006) for DRFS were observed per additional marker showing high expression. CONCLUSIONS: The studied epigenetic markers showed clinical prognostic value in colorectal cancer, both as individual markers and when combined into multimarker analyses. These results indicate that epigenetic mechanisms play an important role in colorectal carcinogenesis.


Subject(s)
Biomarkers, Tumor/genetics , Colorectal Neoplasms/pathology , Epigenesis, Genetic , Histone Deacetylases/biosynthesis , Histones/metabolism , Aged , Biomarkers, Tumor/analysis , Cell Nucleus/metabolism , Colorectal Neoplasms/mortality , Female , Histone Deacetylases/analysis , Histones/analysis , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Male , Middle Aged , Proportional Hazards Models , Tissue Array Analysis
3.
BMC Cancer ; 14: 531, 2014 Jul 22.
Article in English | MEDLINE | ID: mdl-25047223

ABSTRACT

BACKGROUND: Post-translational modification of histone tails by methylation plays an important role in tumorigenesis. In this study, we investigated the nuclear expression of H3K4me3, H3K9me3 and H4K20me3 in early-stage colon cancer in relation to clinical outcome. METHODS: Tumor tissue cores of 254 TNM stage I-III colorectal cancer patients were immunohistochemically stained for H3K4me3, H3K9me3 and H4K20me3 and scored using the semi-automated Ariol system. Cox proportional hazard trend analyses were performed to assess the prognostic value of the combined markers with respect to patient survival and tumor recurrence. RESULTS: The histone methylation markers only showed prognostic value in early-stage (TNM stage I and II) colon cancer. Therefore, only this patient set (n = 121) was used for further statistical analyses. Low nuclear expression of H3K4me3, and high expression of H3K9me3 and H4K20me3 were associated with good prognosis. In combined marker analyses, the patient group showing most favorable expression (low H3K4me3, high H3K9me3 and high H4K20me3) was associated with the best prognosis. Multivariate trend analyses showed significantly increased hazard ratios (HR) for each additional marker showing unfavorable expression, as compared to the "all favorable" reference group. The HR for disease-free survival was 3.81 (1.72-8.45; p = 0.001), for locoregional recurrence-free survival 2.86 (1.59-5.13; p < 0.001) and for distant recurrence-free survival 2.94 (1.66-5.22; p < 0.001). CONCLUSIONS: Combined nuclear expression of histone modifications H3K4me3, H3K9me3 and H4K20me3 is prognostic in early-stage colon cancer. The combination of expression of the three histone modifications provides better stratification of patient groups as compared to the individual markers and provides a good risk assessment for each patient group.


Subject(s)
Colonic Neoplasms/diagnosis , Colonic Neoplasms/pathology , Histones/metabolism , Neoplasm Recurrence, Local/diagnosis , Neoplasm Recurrence, Local/pathology , Adult , Aged , Aged, 80 and over , Cell Nucleus/metabolism , Colonic Neoplasms/metabolism , Female , Gene Expression Regulation, Neoplastic , Humans , Male , Methylation , Middle Aged , Neoplasm Recurrence, Local/metabolism , Prognosis , Proportional Hazards Models , Survival Analysis , Tissue Array Analysis
4.
Methods Mol Biol ; 1190: 127-41, 2014.
Article in English | MEDLINE | ID: mdl-25015278

ABSTRACT

Toll-like receptors (TLRs) are key components for the recognition of microorganisms, for the initiation of innate immunity, and for promoting adaptive immune responses. TLR signaling in B cells, in addition to B cell receptor or CD40 ligation, plays an important role in B cell differentiation and activation. In contrast, various infectious agents and/or TLR ligands can also prime B cells to induce tolerance and downregulate inflammatory reactions; those B cells are called regulatory B (Breg) cells and are characterized by a dominant IL-10 production. Several studies have suggested that Breg cells are impaired in patients with autoimmune diseases and allergic asthma. However, the role for TLR ligands in the induction of Breg cells as a potential therapy for some of these inflammatory diseases has not yet been investigated. Here, we provide detailed instructions on how to analyze and validate cytokine production in human and mouse B cells in response to various TLR ligands. Furthermore, we describe an assay to investigate the suppressive properties of TLR-induced B cells to confirm their regulatory B cell status.


Subject(s)
B-Lymphocytes, Regulatory/immunology , Cytokines/immunology , Toll-Like Receptors/immunology , Animals , Antigens, CD19/analysis , Antigens, CD19/immunology , B-Lymphocytes, Regulatory/cytology , Cell Separation/methods , Coculture Techniques/methods , Cytokines/analysis , Enzyme-Linked Immunosorbent Assay/methods , Flow Cytometry/methods , Forkhead Transcription Factors/analysis , Forkhead Transcription Factors/immunology , Humans , Immunity, Innate , Interleukin-10/analysis , Interleukin-10/immunology , Mice , T-Lymphocytes, Regulatory/cytology , T-Lymphocytes, Regulatory/immunology , Toll-Like Receptors/analysis
5.
ChemSusChem ; 2(5): 437-41, 2009.
Article in English | MEDLINE | ID: mdl-19370740

ABSTRACT

Furfural, a potential coproduct of levulinic acid, can be converted into levulinic acid via hydrogenation to furfuryl alcohol and subsequent ethanolysis to ethyl levulinate. The ethanolysis reaction is known to proceed in the presence of H(2)SO(4). We show here that several strongly acidic resins are comparably effective catalysts for this reaction. Optimal performance is achieved by balancing the number of acid sites with their accessibility in the resin. Acidic zeolites such as H-ZSM-5 also catalyze this reaction, although with a lower activity and a higher co-production of diethyl ether.


Subject(s)
Furans/chemistry , Ion Exchange Resins/chemistry , Levulinic Acids/chemistry , Polymers/chemistry , Sulfuric Acids/chemistry , Zeolites/chemistry , Catalysis , Hydrogen-Ion Concentration
SELECTION OF CITATIONS
SEARCH DETAIL
...